{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:54:57Z","timestamp":1791618897432,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11239-016-1445-1","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:59:29Z","timestamp":1479171569000},"page":"157-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study"],"prefix":"10.1007","volume":"43","author":[{"name":"and Collaborators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6384-6455","authenticated-orcid":false,"given":"\u00d6zcan","family":"Ba\u015faran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Beton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Tekinalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet \u00c7a\u011fr\u0131","family":"Aykan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Kalayc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Bolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Ta\u015far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zgen","family":"\u015eafak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macit","family":"Kal\u00e7\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"\u0130nci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernas","family":"Alt\u0131nta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedat","family":"Kalkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cevat","family":"K\u0131rma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Biteker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"key":"1445_CR1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","volume":"369","author":"JW Eikelboom","year":"2013","unstructured":"Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ et al (2013) Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 369:1206\u20131214","journal-title":"N Engl J Med"},{"key":"1445_CR2","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719\u20132747","journal-title":"Eur Heart J"},{"key":"1445_CR3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC et al (2014) AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the american college of cardiology\/american heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol 64:e1\u201376","journal-title":"J Am Coll Cardiol"},{"key":"1445_CR4","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","volume":"17","author":"H Heidbuchel","year":"2015","unstructured":"Heidbuchel H, Verhamme P, Alings M, Antz M, Diener H-C, Hacke W et al (2015) Updated european heart rhythm association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17:1467\u20131507","journal-title":"Europace"},{"key":"1445_CR5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891","journal-title":"N Engl J Med"},{"key":"1445_CR6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"key":"1445_CR7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJV, Lopes RD, Hylek EM, Hanna M et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992","journal-title":"N Engl J Med"},{"key":"1445_CR8","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy S a, Wiviott SD, Halperin JL et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093\u20132104","journal-title":"N Engl J Med"},{"key":"1445_CR9","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/europace\/euu178","volume":"16","author":"M Molteni","year":"2014","unstructured":"Molteni M, Polo Friz H, Primitz L, Marano G, Boracchi P, Cimminiello C (2014) The definition of valvular and non-valvular atrial fibrillation: results of a physicians\u2019 survey. Europace 16:1720\u20131725","journal-title":"Europace"},{"key":"1445_CR10","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1093\/eurheartj\/ehu305","volume":"35","author":"G Breithardt","year":"2014","unstructured":"Breithardt G, Baumgartner H, Berkowitz SD, Hellkamp AS, Piccini JP, Stevens SR et al (2014) Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. Eur Heart J 35:3377\u20133385","journal-title":"Eur Heart J"},{"key":"1445_CR11","doi-asserted-by":"publisher","unstructured":"Di Biase L (2016) Use of direct oral anticoagulants in patients with atrial fibrillation and valvular heart lesions. J Am Heart Assoc 5. doi: 10.1161\/JAHA.115.002776","DOI":"10.1161\/JAHA.115.002776"},{"issue":"3","key":"1445_CR12","first-page":"215","volume":"44","author":"\u00d6 Ba\u015faran","year":"2016","unstructured":"Ba\u015faran \u00d6, Do\u011fan V, Memic Sancar K, Altun \u0130, Mert KU, Mert G\u00d6 et al (2016) Rationale, design and methodology of the RAMSES Study: ReAl-life multicenter survey evaluating stroke prevention strategies. Turk Kardiyol Dern Ars 44(3):215\u2013220","journal-title":"Turk Kardiyol Dern Ars"},{"key":"1445_CR13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093\u20131100","journal-title":"Chest"},{"key":"1445_CR14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263\u2013272","journal-title":"Chest"},{"key":"1445_CR15","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","volume":"33","author":"A Vahanian","year":"2012","unstructured":"Vahanian A, Alfieri O, Andreotti F, Antunes MJ et al (2012) Joint Task Force on the management of valvular heart disease of the european society of cardiology (ESC), European association for cardio-thoracic surgery (EACTS), guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451\u20132496","journal-title":"Eur Heart J"},{"key":"1445_CR16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","volume":"61","author":"JL Blackshear","year":"1996","unstructured":"Blackshear JL, Odell JA (1996) Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 61:755\u2013759","journal-title":"Ann Thorac Surg"},{"key":"1445_CR17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","volume":"16","author":"GYH Lip","year":"2014","unstructured":"Lip GYH, Laroche C, Dan G-A, Santini M, Kalarus Z, Rasmussen LH et al (2014) A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace 16:308\u2013319","journal-title":"Europace"},{"key":"1445_CR18","doi-asserted-by":"crossref","first-page":"A325","DOI":"10.1016\/S0735-1097(14)60325-9","volume":"63","author":"MD Ezekowitz","year":"2014","unstructured":"Ezekowitz MD, Parise H, Nagarakanti R, Noack H, Brueckmann M, Clemens A et al (2014) Comparison of dabigatran versus warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY\u00ae trial. J Am Coll Cardiol 63:A325","journal-title":"J Am Coll Cardiol"},{"key":"1445_CR19","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/heartjnl-2015-308120","volume":"102","author":"G Breithardt","year":"2016","unstructured":"Breithardt G, Baumgartner H, Berkowitz SD, Hellkamp AS, Piccini JP, Lokhnygina Y et al (2016) Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban. Heart 102:1036\u20131043","journal-title":"Heart"},{"key":"1445_CR20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.014807","volume":"132","author":"A Avezum","year":"2015","unstructured":"Avezum A, Lopes RD, Schulte PJ, Lanas F, Gersh BJ, Hanna M et al (2015) Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Circulation 132:624\u2013632","journal-title":"Circulation"},{"key":"1445_CR21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2459\/JCM.0000000000000236","volume":"16","author":"G Boriani","year":"2015","unstructured":"Boriani G, Cimaglia P, Fantecchi E, Mantovani V, Ziacchi M, Valzania C et al (2015) Non-valvular atrial fibrillation: potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants. J Cardiovasc Med (Hagerstown) 16:491\u2013496","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"1445_CR22","first-page":"734","volume":"16","author":"\u00d6 Ba\u015faran","year":"2016","unstructured":"Ba\u015faran \u00d6, Beton O, Do\u011fan V, Tekinalp M, Aykan A\u00c7, Kalayc\u0131o\u011flu E et al (2016) ReAl-life multicenter survey evaluating stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study). Anatol J Cardiol 16:734\u2013741","journal-title":"Anatol J Cardiol"},{"key":"1445_CR23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/CIRCULATIONAHA.111.019935","volume":"125","author":"AE Darby","year":"2012","unstructured":"Darby AE, Dimarco JP (2012) Management of atrial fibrillation in patients with structural heart disease. Circulation 125:945\u2013957","journal-title":"Circulation"},{"key":"1445_CR24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0735-1097(02)01922-8","volume":"40","author":"F Grigioni","year":"2002","unstructured":"Grigioni F, Avierinos J-F, Ling LH, Scott CG, Bailey KR, Tajik AJ et al (2002) Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 40:84\u201392","journal-title":"J Am Coll Cardiol"},{"key":"1445_CR25","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","volume":"82","author":"WB Kannel","year":"1998","unstructured":"Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N\u20139N","journal-title":"Am J Cardiol"},{"key":"1445_CR26","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1002\/clc.20433","volume":"32","author":"CK Nair","year":"2009","unstructured":"Nair CK, Aronow WS, Shen X, Anand K, Holmberg MJ, Esterbrooks DJ (2009) Effect of mitral regurgitation on cerebrovascular accidents in patients with atrial fibrillation and left atrial thrombus. Clin Cardiol 32:E7\u2013E10","journal-title":"Clin Cardiol"},{"key":"1445_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0167-5273(99)00208-9","volume":"72","author":"Y Miyasaka","year":"2000","unstructured":"Miyasaka Y, Tsuji H, Tokunaga S, Nishiue T, Yamada K, Watanabe J et al (2000) Mild mitral regurgitation was associated with increased prevalence of thromboembolic events in patients with nonrheumatic atrial fibrillation. Int J Cardiol 72:229\u2013233","journal-title":"Int J Cardiol"},{"key":"1445_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/1076029615614395","author":"O Basaran","year":"2015","unstructured":"Basaran O, Filiz Basaran N, Cekic EG, Altun I, Dogan V, Mert GO et al (2015) PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study). Clin Appl Thromb Hemost. doi: 10.1177\/1076029615614395","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-016-1445-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:35:26Z","timestamp":1498347326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-016-1445-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1445"],"URL":"https:\/\/doi.org\/10.1007\/s11239-016-1445-1","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,15]]}}}